Mechanistically, CLTB enhances the cellular uptake of sEVs by coordinating the NF‐κB–proliferating cell nuclear antigen (PCNA) clamp‐associated factor (PCLAF/KIAA0101) axis, thereby promoting HCC progression. Here, PCNA is linked to hepatocellular carcinoma.